Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04483505Phase 1Completed
Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.
Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast
PrincipalinvestigatorStart date: 2020-11-25

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Miguel Ángel Quintela-Fandino

Centro Nacional de Investigaciones Oncológicas

Related
1 trials

Shared therapeutic areas:

Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Apices Soluciones S.L.Bayer+2 more
Collaborated on 1 trial
Similarity Score24%

Luis Manso, MD

Hospital Universitario 12 de Octubre

Related
1 trials

Shared therapeutic areas:

Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Apices Soluciones S.L.Bayer+2 more
Collaborated on 1 trial
Similarity Score24%

Fabrice ANDRE, MD

Gustave Roussy, Cancer Campus, Grand Paris

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic

Worked with same sponsors:

Pfizer
Similarity Score15%

Michelle Melisko, MD

University of California, San Francisco

Related
5 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Bushra Shirazi

Sindh Institute of Urology and Transplantation

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Nicola Fusco, MD

Istituto Europeo di Oncologia

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Takayuki Ueno, MD,PhD

Cancer Institute Hospital of JFCR, Department Director, Breast Surgical Oncology Department

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Pfizer
Similarity Score15%

Masakazu Toi, MD,PhD

Kyoto University, Professor of Breast Surgery Department

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Pfizer
Similarity Score15%

Antonio Llombart-Cussac

Arnau de Vilanova Hospital, Valencia (Spain)

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Antonio Llombart

MedSIR

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04483505Phase 1PrincipalInvestigator

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast
Completed

All 1 trials loaded